Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

PCOS is likely inherited in families, increasing risk for first-degree relatives.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Obese and lean women with PCOS have different symptoms and need different treatments.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

PCOS is common in women, often treated with lifestyle changes and oral contraceptives.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

PCOS affects many young women in KSA, with mild cases being most common.

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

High androgen levels in young women with PCOS are linked to higher blood pressure.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.